COMP <GO>
RAPP vs VSTM // REVENUE GROWTH (YOY)
Rapport Therapeutics Inc. (NASDAQ) VS. Verastem Inc. (NASDAQ) • 15-METRIC TALLY: RAPP 2
— VSTM 3
■ METRIC PARITY
LAST: $24.21 (+7.60%) • MKT CAP: $1.16B
revenue-growth
—
LAST: $9.66 (-1.78%) • MKT CAP: $1.17B
revenue-growth
180.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (RAPP VS. VSTM)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | RAPP | VSTM | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -22.90% | -35.00% | +12.10 | RAPP | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -7.58% | -11.72% | +4.14 | RAPP | /fcf-yield <GO> |
| Operating Margin | — | -60.00% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | -60.00% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | — | 180.00% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 0.20 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 2/9 | 3/9 | -1.00 | VSTM | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 37.5 | 61.7 | -24.12 | VSTM | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.16B | $1.17B | -$11.4M | VSTM | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | RAPP REV | VSTM REV | RAPP GROSS % | VSTM GROSS % | RAPP FCF | VSTM FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $30.9M | — | — | -$88.1M | -$137.5M |
| FY 2024 | $0 | $10.0M | — | — | -$67.2M | -$104.8M |
| FY 2023 | $0 | $0 | — | — | -$27.2M | -$86.5M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
RAPP // BETA —
VSTM // BETA —